Published in Virology on April 05, 2015
BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol (2007) 74.13
Avoiding false positives with PCR. Nature (1989) 30.66
RDP3: a flexible and fast computer program for analyzing recombination. Bioinformatics (2010) 9.49
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology (2005) 9.39
Genetic diversity and evolution of hepatitis C virus--15 years on. J Gen Virol (2004) 6.67
Course and outcome of hepatitis C. Hepatology (2002) 6.51
Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature (2005) 6.21
Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol (2014) 4.82
Evolutionary analysis of the dynamics of viral infectious disease. Nat Rev Genet (2009) 4.56
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology (2014) 4.15
Treating viral hepatitis C: efficacy, side effects, and complications. Gut (2006) 3.71
Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol (1994) 2.90
Sequence analysis of the core gene of 14 hepatitis C virus genotypes. Proc Natl Acad Sci U S A (1994) 2.83
Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5' untranslated region sequences. J Clin Microbiol (2007) 2.55
The origin of hepatitis C virus genotypes. J Gen Virol (1997) 2.26
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat (2014) 2.23
The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis. PLoS Med (2009) 2.06
Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis. J Infect Dis (2004) 1.85
The hepatitis C virus epidemic among injecting drug users. Infect Genet Evol (2005) 1.70
A comprehensive system for consistent numbering of HCV sequences, proteins and epitopes. Hepatology (2006) 1.65
Analysis for free: comparing programs for sequence analysis. Brief Bioinform (2004) 1.63
Iatrogenic transmission of human T cell lymphotropic virus type 1 and hepatitis C virus through parenteral treatment and chemoprophylaxis of sleeping sickness in colonial Equatorial Africa. Clin Infect Dis (2010) 1.49
HCV 6a prevalence in Guangdong province had the origin from Vietnam and recent dissemination to other regions of China: phylogeographic analyses. PLoS One (2012) 1.44
Phylogenetic analysis of hepatitis C virus isolates indicates a unique pattern of endemic infection in Cameroon. J Gen Virol (2003) 1.39
Clinical consequences of hepatitis C virus infection. Rev Med Virol (2003) 1.27
Emergence of hepatitis C virus genotype 4: phylogenetic analysis reveals three distinct epidemiological profiles. J Clin Microbiol (2009) 1.24
Investigating the endemic transmission of the hepatitis C virus. Int J Parasitol (2007) 1.14
Distribution and heterogeneity of hepatitis C genotypes in hepatitis patients in Cameroon. J Med Virol (2005) 1.04
Los Alamos hepatitis C virus sequence and human immunology databases: an expanding resource for antiviral research. Antivir Chem Chemother (2007) 1.02
Phylogeography, risk factors and genetic history of hepatitis C virus in Gabon, central Africa. PLoS One (2012) 1.02
Colonial history and contemporary transmission shape the genetic diversity of hepatitis C virus genotype 2 in Amsterdam. J Virol (2012) 1.02
Whole genome pyrosequencing of rare hepatitis C virus genotypes enhances subtype classification and identification of naturally occurring drug resistance variants. J Infect Dis (2012) 0.94
Hepatitis C virus-specific directly acting antiviral drugs. Curr Top Microbiol Immunol (2013) 0.93
Phylogeography and epidemic history of hepatitis C virus genotype 4 in Africa. Virology (2014) 0.92
Eight novel hepatitis C virus genomes reveal the changing taxonomic structure of genotype 6. J Gen Virol (2012) 0.92
Full-length sequences of 11 hepatitis C virus genotype 2 isolates representing five subtypes and six unclassified lineages with unique geographical distributions and genetic variation patterns. J Gen Virol (2012) 0.92
Complete genomes of hepatitis C virus (HCV) subtypes 6c, 6l, 6o, 6p and 6q: completion of a full panel of genomes for HCV genotype 6. J Gen Virol (2007) 0.91
Hepatitis C virus genotype 4d in Southern Italy: reconstruction of its origin and spread by a phylodynamic analysis. J Med Virol (2012) 0.90
Characterization of full-length hepatitis C virus sequences for subtypes 1e, 1h and 1l, and a novel variant revealed Cameroon as an area in origin for genotype 1. J Gen Virol (2013) 0.90
Complete genomic sequences for hepatitis C virus subtypes 4b, 4c, 4d, 4g, 4k, 4l, 4m, 4n, 4o, 4p, 4q, 4r and 4t. J Gen Virol (2009) 0.89
Full-length genome sequences of five hepatitis C virus isolates representing subtypes 3g, 3h, 3i and 3k, and a unique genotype 3 variant. J Gen Virol (2012) 0.87
Origin of hepatitis C virus genotype 3 in Africa as estimated through an evolutionary analysis of the full-length genomes of nine subtypes, including the newly sequenced 3d and 3e. J Gen Virol (2014) 0.86
Detection and clinical features of hepatitis C virus type 6 infections in blood donors from Hong Kong. J Med Virol (1996) 0.85
Full genome sequence of three isolates of hepatitis C virus subtype 4b from Portugal. Arch Virol (2008) 0.82
An expanded taxonomy of hepatitis C virus genotype 6: Characterization of 22 new full-length viral genomes. Virology (2015) 0.76
Characterization of full-length hepatitis C virus sequences for subtypes 1e, 1h and 1l, and a novel variant revealed Cameroon as an area in origin for genotype 1. J Gen Virol (2013) 0.90
Origin of hepatitis C virus genotype 3 in Africa as estimated through an evolutionary analysis of the full-length genomes of nine subtypes, including the newly sequenced 3d and 3e. J Gen Virol (2014) 0.86
The phosphorylation of α-synuclein: development and implication for the mechanism and therapy of the Parkinson's disease. J Neurochem (2015) 0.76